Quest Diagnostics' LifeLabs Buy Could Boost Earnings by 4% to 5% -- Market Talk
1145 ET - Quest Diagnostics acquiring LifeLabs could be 4% to 5% accretive to its earnings in fiscal 2025, UBS analysts say, assuming the lab-test provider grows 5% annually and Quest uses a fairly eq
Baird Raises Price Target on Laboratory Corp of America to $261 From $258
Laboratory Corp of America Holdings (LH) has an average rating of outperform and price targets ranging from $210 to $262, according to analysts polled by Capital IQ. Price: 204.20, Change: +0.34, Perc
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
BURLINGTON, N.C., July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 20
The Past Three Years for Labcorp Holdings (NYSE:LH) Investors Has Not Been Profitable
Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report
Is Labcorp Holdings Inc. (NYSE:LH) Potentially Undervalued?
Express News | Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
Top Shorted S&P 500 Industrial Stocks at May End
Express News | Labcorp : Baird Raises Target Price to $258 From $256
What Is Labcorp Holdings Inc.'s (NYSE:LH) Share Price Doing?
Labcorp Holdings Inc. (NYSE:LH) received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$219 at one point, and dropping to the lows of US$19
HSBC Adjusts Price Target on Laboratory Corp of America Holdings to $210 From $225, Keeps Hold Rating
Laboratory Corp of America Holdings (LH) has an average outperform rating and a price target range of $210 to $262, according to analysts polled by Capital IQ. Price: 195.99, Change: -0.69, Percent Ch
Express News | Labcorp : HSBC Cuts Target Price to $210 From $225
Labcorp Holdings (LH) Is Trading at an Attractive Valuation
Sell Ideas in Staples and Health Care - Oppenheimer
Labcorp Announces New Strategic Service Offerings Within Precision Oncology Portfolio
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced new strategic service offerings within its...
Laboratory Corp. Is Maintained at Overweight by JP Morgan
Laboratory Corp. Is Maintained at Overweight by JP Morgan
Laboratory Corp. Price Target Cut to $243.00/Share From $261.00 by JP Morgan
Laboratory Corp. Price Target Cut to $243.00/Share From $261.00 by JP Morgan
Komo: Maintaining the Labcorp Holdings (LH.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $261.00 to $243.00.
Komo: Maintaining the Labcorp Holdings (LH.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $261.00 to $243.00.
JP Morgan Maintains Overweight on Labcorp Holdings, Lowers Price Target to $243
JP Morgan analyst Lisa Gill maintains Labcorp Holdings with a Overweight and lowers the price target from $261 to $243.
Labcorp Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 26.23% JP Morgan $261 → $243 Maintains Overweight 04/26/2024 32.47% Truist Securities $270 → $2
JPMorgan Adjusts Price Target on Laboratory Corp of America Holdings to $243 From $261
Laboratory Corp of America Holdings (LH) has an average outperform rating and a price target range of $210 to $261, according to analysts polled by Capital IQ.